Skip to content

Author

E. Vijverberg

We have 4 of 131 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Alzheimer's disease genetics converges on microglial and neuronal dysregulation.

Alzheimer's disease (AD) is the most common cause of dementia, with global case numbers projected to reach 153 million in 20501. AD is highly heritable, with twin-based heritability estimates of 60-80%2. Although 1,200 causal loci are predicted to exist for AD3, approximately 80 loci have been associated with AD in two...

E. Uffelmann, D. Wightman, S. Bahrami et al. · 0 citations
Open access Oct 2026

Location matters: Attributing cognitive symptoms to white matter hyperintensities in 3,481 memory clinic patients.

Considering location of WMHs increased their diagnostic relevance, compared to total volume, explaining more variance in attention and executive function, processing speed and verbal memory, advocates considering WMH location beyond total volume as a diagnostic marker.

Ewoud J. van der Lelij, Mirthe Coenen, F. de Kort et al. · 1 citation
Open access Oct 2026

Cholesteryl ester transfer protein (CETP) inhibition and high-density lipoprotein particle composition: consequences for atherogenesis and neurodegeneration

Cholesteryl ester transfer protein (CETP), required for transferring triglyceride from very-low-density lipoprotein in exchange for cholesteryl ester from high-density lipoprotein (HDL), is also involved in lipophilic antioxidant exchange. We aimed to determine the effects of the next generation potent CETP inhibitor...

Eric J. Niesor, M. Ditmarsch, Serge Rezzi et al. · 1 citation
Open access Jul 2026

Neuropsychological profiles and behavioural correlates in individuals exposed to repetitive head impacts: findings from the NEwTON study

No association between cognitive function and behavioural disinhibition is found in populations at risk for CTE, and longitudinal studies employing neuroimaging and biomarker data are needed to disentangle the underlying pathology in populations at risk for CTE.

Suzie Kamps, Esmé H. J. Habraken, S. van Amerongen et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.